Zevra Therapeutics Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Zevra Therapeutics, Inc. (ZVRA)

8.91 -0.06 (-0.67%) USD | NASDAQ | Feb 25, 16:00

8.91 0.00 (0.00%) After-Hours: 20:00

View Preferred Securities out of Shareholders Equity (Quarterly) for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Verastem, Inc.	Upgrade
ADMA Biologics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--